- BioStem to Showcase its Leading BioREtain® Technology at the Symposium for Advanced Wound Care (SAWC) Spring Meeting
- Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights
- Cytokinetics to Participate in May Investor Conferences
- RAGE Inhibitor Pipeline Insight Report 2025 Analyzes RAGE Inhibitor Drugs, Key Players, and Development Activities
- PharmAla Issues Q2 Financial Statements
- BioStem Technologies to Host First Quarter 2025 Financial Results Conference Call on May 12, 2025
- Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2025 Annual Meeting and Retina World Congress
- Compass Therapeutics Presents Data on Enhanced Efficacy of CTX-471 in Combination with Tovecimig in Checkpoint-Refractory Models at the American Association for Cancer Research (AACR) Annual Meeting
- Ampersand Biomedicines Presents Preclinical Data on AMP-410, a Novel Anti-VEGF/4-1BB Bifunctional AND-Body™ Therapeutic, at AACR 2025
- Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)
